Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Fehrman

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Transplantation|June 14, 2000
Kidney donors don't regret: follow-up of 370 donors in Stockholm since 1964I Fehrman-Ekholm, B Brink, C Ericsson, et al.
Transplantation Proceedings|December 21, 2010
Long-term follow-up of living liver donorsM Castedal, M Andersson, D Polanska-Tamborek, et al.
Transplantation Proceedings|August 1, 1988
A clear distinction between "immune activation of rejection" and "no immune activation" in liver transplant aspiration cytologyC L Greene, I Fehrman, G W Tillery, et al.
Transplantation Proceedings|June 1, 1988
Influence of early cyclosporine dosage and plasma and whole blood levels on acute rejections in cadaveric renal allograft recipientsA Lindholm, G Lundgren, I Fehrman, et al.
Transplantation Proceedings|September 1, 1982
Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapyG Lundgren, I Fehrman, R Gunnarsson, et al.
Transplantation Proceedings|March 31, 2009
Single or double arteries in the remnant kidney after donation: influence on the long-term outcome of the donorI Fehrman-Ekholm, S Möller, J Steinwall, et al.
Transplantation Proceedings|February 1, 1989
Liver transplant aspiration cytology (TAC) at three weeks and one year in healthy recipients with grafts free of histologic abnormalityC L Greene, I Fehrman, D Nery, et al.
Transplantation Proceedings|October 1, 1987
Improved renal graft function in triple-drug treatment with low-dose cyclosporineH Persson, C Andersson, C Lundgren, et al.
Transplantation Proceedings|February 1, 1997
The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion GroupH E Wilczek, E Berglin, I Blohmé, et al.
Transplantation Proceedings|February 1, 1990
Measures to decrease HLA antibodies in immunized patients awaiting kidney transplantationI Fehrman, P Barany, S Björck, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Transplantation|June 14, 2000
Kidney donors don't regret: follow-up of 370 donors in Stockholm since 1964I Fehrman-Ekholm, B Brink, C Ericsson, et al.
Transplantation Proceedings|December 21, 2010
Long-term follow-up of living liver donorsM Castedal, M Andersson, D Polanska-Tamborek, et al.
Transplantation Proceedings|August 1, 1988
A clear distinction between "immune activation of rejection" and "no immune activation" in liver transplant aspiration cytologyC L Greene, I Fehrman, G W Tillery, et al.
Transplantation Proceedings|June 1, 1988
Influence of early cyclosporine dosage and plasma and whole blood levels on acute rejections in cadaveric renal allograft recipientsA Lindholm, G Lundgren, I Fehrman, et al.
Transplantation Proceedings|September 1, 1982
Cadaveric renal transplantation in patients over 55 years of age with special emphasis on immunosuppressive therapyG Lundgren, I Fehrman, R Gunnarsson, et al.
Transplantation Proceedings|March 31, 2009
Single or double arteries in the remnant kidney after donation: influence on the long-term outcome of the donorI Fehrman-Ekholm, S Möller, J Steinwall, et al.
Transplantation Proceedings|February 1, 1989
Liver transplant aspiration cytology (TAC) at three weeks and one year in healthy recipients with grafts free of histologic abnormalityC L Greene, I Fehrman, D Nery, et al.
Transplantation Proceedings|October 1, 1987
Improved renal graft function in triple-drug treatment with low-dose cyclosporineH Persson, C Andersson, C Lundgren, et al.
Transplantation Proceedings|February 1, 1997
The Swedish nationwide experience of converting transplant patients treated with Sandimmun to the new galenic formulation Sandimmun-neoral. The Swedish Sandimmun-Neoral Conversion GroupH E Wilczek, E Berglin, I Blohmé, et al.
Transplantation Proceedings|February 1, 1990
Measures to decrease HLA antibodies in immunized patients awaiting kidney transplantationI Fehrman, P Barany, S Björck, et al.
Pageof 6